AstraZeneca begins Phase III trial of Covid-19 vaccine in US
AstraZeneca has expanded the clinical development of its potential Covid-19 vaccine candidate AZD1222 in the...
Sanofi provides update on Kevzara Phase 3 trial in severe and critically ill COVID-19...
Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara® (sarilumab) at a...
Piramal Pharma to Collaboratewith Epirium Bio on Exclusive Integrated Development & Manufacturing Program for...
Piramal Pharma Solutions, a leading contract development and manufacturing organization (CDMO), today announced that the...
Bayer submits vericiguat for marketing authorization in China for the treatment of chronic heart...
Bayer announced the submission of the regulatory application seeking the approval of vericiguat in China....
Gilead’s Investigational Antiviral Veklury Receives U.S. FDA Emergency Use Authorization for the Treatment of...
Gilead Sciences, Inc. announced the U.S. FDA expanded the EUA enabling use of the investigational...
Chiesi Group and JAGGAER Drive Strategic Supplier Management and Procurement Excellence
Chiesi Group, an international pharmaceutical corporation focused on research, development, and production of innovative medicines,...
Bruker and Purity-IQ sign partnership agreement to transform the cannabis regulatory landscape
Bruker and Purity-IQ have joined forces to create a powerful new testing system for medical...
Novavax to Supply 76M Doses of COVID-19 Vax to Canada
Novavax, Inc. has reached an agreement in principle with the Government of Canada to supply...
FDA Clears SPI’s Ebselen for Phase II COVID-19 Trials
Sound Pharmaceuticals, Inc. (SPI) received clearance from the FDA to begin two Phase 2 studies...
Alcami Providing Commercial Manufacturing for Trevena’s Recently FDA Approved OLINVYK
Alcami, a US-based contract development and manufacturing organization (CDMO), announced that it is providing commercial...
